Although NSCLC cells expressing wild-type EGFR do not respond to clinically relevant concentrations of EGFR-TKIs their proliferation appears to depend to some degree on EGFR signaling as has been shown by EGFR knockdown experiments [9], [10], [11], [12]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.